KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Neurosurgery / 2019 / Cilt: 29 - Sayı: 5

Neuroprotective Effects of Lacosamide in Experimental Traumatic Spinal Cord Injury in Rats

Serdar DEMIROZ
Sevki ERDEM
Aykut ULUCAN
Koray UR
Aydin Sukru BENGU
Feyza DEMIRALIN UR
Ozlem Oz GERGIN
Sayfa
718–723
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There were statisticallysignificant differences between Group 3 and the others in their PND score, serum MDA, SOD, GPX and catalase levels (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIM: To evaluate the effects of lacosamide on traumatic spinal cord injury (SCI) in rats.MATERIAL and METHODS: A total of 28 male Wistar albino rats, each weighing 300–350 g, were included.
📊
Temel Bulgular & Veri:In Group 1, only a laminectomy was performed; in Group 2, SCI was performed after laminectomy; inGroup 3, SCI was performed after laminectomy followed by lacosamide administration, and in Group 4, SCI was performed afterlaminectomy followed by physiological saline administration.
💡
Sonuç & Katkı:There were statisticallysignificant differences between Group 3 and the others in their PND score, serum MDA, SOD, GPX and catalase levels (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

AIM: To evaluate the effects of lacosamide on traumatic spinal cord injury (SCI) in rats.MATERIAL and METHODS: A total of 28 male Wistar albino rats, each weighing 300–350 g, were included. They were randomlyassigned to four groups. In Group 1, only a laminectomy was performed; in Group 2, SCI was performed after laminectomy; inGroup 3, SCI was performed after laminectomy followed by lacosamide administration, and in Group 4, SCI was performed afterlaminectomy followed by physiological saline administration. After 48 hours, all animals were sacrificed, blood samples were drawn,and their spinal cords were removed. The serum levels of catalase, glutathione peroxidase (GPx), superoxide dismutase (SOD) andmalondialdehyde (MDA) were measured, and the spinal cord specimens were examined for neuronal degeneration (PND).RESULTS: The MDA level was the lowest and the antioxidant enzyme levels were the highest in Group 3. There were statisticallysignificant differences between Group 3 and the others in their PND score, serum MDA, SOD, GPX and catalase levels (p

🔖

Bu Makaleye Atıf Yap

DEMIROZ, S., ERDEM, S., ULUCAN, A., UR, K., BENGU, A. S., UR, F. D., GERGIN, O. O. (2022). Neuroprotective Effects of Lacosamide in Experimental Traumatic Spinal Cord Injury in Rats. Turkish Neurosurgery, Cilt: 29 - Sayı: 5, 718–723. https://ajindex.com/articles/616900

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Ahn JY, Yan BC, Park JH, Ahn JH, Lee DH, Kim IH, Cho JH, Chen BH, Lee JC, Cho YS, Shin MC, Cho JH, Hong S, Won MH, Kim SK: Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke. ExpTher Med 10:2007–2014, 2015 2. Bell MT, Puskas F, Agoston VA, Cleveland JC Jr, Freeman KA, Gamboni F, Herson PS, Meng X, Smith PD, Weyant MJ, Fullerton DA, Reece TB: Toll-like receptor 4 dependent microglial activation mediates spinal cord ischemiare perfusion injury. Circulation 128 Suppl 1:152-156, 2013 3. Celik H, Karatay M, Erdem Y, Yildirim AE, Sertbas I, Karatay E, Kul H, Guvenc Y, Koksal I, Menekse G, Alagoz F, Kertmen HH, Caydere M:. The biochemical, histopathological and clinical comparison of the neuroprotective effects of subcutaneous adalimumab and intravenous methylprednisolone in an experimental compressive spinal cord trauma model. Turk Neurosurg 26:622-631, 2016 4. Choi HY, Park JH, Chen BH, Shin BN, Lee YL, Kim IH, Cho JH, Lee TK, Lee JC, Won MH, Ahn JH, Tae HJ, Yan BC, Hwang IK, Cho JH, Kim YM, Kim SK:Increases of catalase and glutathione peroxidase expressions by lacosamide pretreatment contributes to neuroprotection against experimentally induced transient cerebral ischemia. Neurochem Res 41:2380-2390, 2016 5. De Girolami U, Frosch MP, Tator CH: Regional neuropathology diseases of the spinal cord and vertebral column. In: Graham DI, Lantos PL, (eds). Greenfield’s Neuropathology, 7th ed. London: Arnold, 2002:1063–1101 6. Erol FS, Kaplan M, Tiftikci M, Yakar H, Ozercan I, Ilhan N, Topsakal C: Comparison of the effects of octreotide and melatonin in preventing nerve injury in rats with experimental spinal cord injury. J Clin Neurosci 15:784-790, 2008 7. Faden AI: Therapeutic approaches to spinal cord injury. Adv Neurol 72: 377-386, 1997 8. Faden AI, Salzman S: Pharmacological strategies in CNS trauma. Trends Pharmacol Sci 13:2935, 1992 9. Fedchenko N, Reifenrath J: Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue – a review. Diagn Pathol 9:221, 2014 10. Gal P, Kravcukova P, Mokry M, Kluchova D: Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: A review. Cell Mol Neurobiol 29:1025- 1035, 2009 11. Hall ED, Braughler JM: Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lip